Get the Stockscreener App
12.15
0.33%
-0.144
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast
The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $12.15. The highest analyst price target is $0.00, and the lowest is $0.00.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00
(-100.00% Downside)
Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.93 | Neutral |
| STOCH(9,6) | 79.95 | Neutral |
| STOCHRSI(14) | 89.05 | Sell |
| MACD(12,26) | 0.1962 | Buy |
| ADX(14) | 24.50 | Neutral |
| William %R | -10.85 | Sell |
| CCI(14) | 89.10 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
11.49
Buy
|
11.74
Buy
|
| MA20 |
11.52
Buy
|
11.58
Buy
|
| MA50 |
11.09
Buy
|
11.08
Buy
|
| MA100 |
6.3522
Buy
|
0.00
Buy
|
| MA200 |
3.1761
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, BBOT could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on BBOT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.93 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 79.95 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 89.05 indicates that BBOT is oversold. This suggests that BBOT price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.5 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 89.1 indicates that BBOT is still overbought but not to an extreme extent.
Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast
1.73%
0.56%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):